Friday 7 May 2021
Home      All news      Contact us      RSS      India
business-standard - 3 days ago

Bajaj Healthcare soars on launching Favipiravir tablets for COVID-19 treatment

Bajaj Healthcare jumped 11.56% to Rs 586.80 after the company announced the launch antiviral Favipiravir tablets, under the brand name Favijaj, for the treatment of mild to moderate COVID-19.


Latest News
Hashtags:   

Bajaj

 | 

Healthcare

 | 

soars

 | 

launching

 | 

Favipiravir

 | 

tablets

 | 

COVID

 | 

treatment

 | 

Sources